Follow onto clinical trial
Ended Definitive Contract Awarded Last action
- Contract number
- 00268199303D260932109
- Awardee
-
Brigham & Womens Hospital Inc. UEI QN6MS4VN7BD1 Part of Partners Healthcare System Incorporated
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,621,324
Award facts
- Contract value 8% obligated
- $19,298,282.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- Not on record
- Set-aside
- No set-aside
- Competition
- Follow On to Competed Action · 39 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Award Fee
- Place of performance
- Boston, MA 02115, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | -$88,565 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $264,616 | |
| Funding Only Action | $257,969 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Additional Work (new agreement, FAR part 6 applies) | $1,187,304 | |
| Original award | $0 |
About this award
This federal contract award was issued by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Brigham & Women's Hospital Inc., a subsidiary of the Partners Healthcare System, to conduct a "FOLLOW ONTO CLINICAL TRIAL". The cost-plus-award-fee contract has a ceiling value of $19,298,282.02 and an ultimate completion date of December 11, 2013. Brigham & Women's Hospital, as a major academic medical center and research institution, has a long history of receiving federal contract and grant awards to support cutting-edge biomedical and clinical research across various medical specialties. This contract does not appear to have any small business set-aside designation. Brigham & Women's Hospital also holds an indefinite delivery contract (IDV) from the Department of Veterans Affairs Veterans Health Administration for genomic medicine research support services, with a ceiling value of $1,480,427 and a period of performance through May 2029.
Quick answers
Who was awarded contract 00268199303D260932109?
00268199303D260932109 was awarded to Brigham & Womens Hospital Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on June 27, 2005.
How much is contract 00268199303D260932109 worth?
The government has obligated $1,621,324 on 00268199303D260932109. Its current value, with exercised options, is $19,298,282.
Was contract 00268199303D260932109 competed?
The extent of competition for 00268199303D260932109 was follow on to competed action. The government received 39 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award